SCHEMBL13508207

SCHEMBL13508207

c1ccc(-c2c3ccccc3c(-c3ccc4c(c3)oc3c5oc6cc(-c7c8ccccc8c(-c8ccccc8-c8cccc9ccccc89)c8ccccc78)ccc6c5c5ccccc5c43)c3ccccc23)c(-c2cccc3ccccc23)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.36
▸ HSD17B10 Q99714 3/20 0.36
▸ HPGD P15428 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ TSHR P16473 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ CASP1 P29466 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ PSD A5PKW4 1/20 0.36
▸ MAOA P21397 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ ALOX5 P09917 1/20 0.35
▸ ESR1 P03372 1/20 0.33
▸ ESR2 Q92731 1/20 0.33
▸ GPR84 Q9NQS5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13508087 0.95 PSD (0.39) ALDH1A1HSD17B10HPGDL3MBTL1TSHR
SCHEMBL13507165 0.91 MAOA (0.39) ALDH1A1HSD17B10HPGDL3MBTL1TSHR
SCHEMBL16067736 0.90 PSD (0.38) ALDH1A1HSD17B10HPGDPSDKDM4E
SCHEMBL27264722 0.87 L3MBTL1 (0.38) ALDH1A1HSD17B10HPGDL3MBTL1PSD
SCHEMBL27329519 0.87 ALOX5 (0.46) ALDH1A1HSD17B10HPGDPSDMAOA
SCHEMBL19108549 0.86 ALOX5 (0.40) ALDH1A1HSD17B10HPGDL3MBTL1PSD
SCHEMBL17944787 0.86 ALOX5 (0.38) ALDH1A1HSD17B10HPGDPSDKDM4E
SCHEMBL16067933 0.86 PSD (0.36) ALDH1A1HSD17B10HPGDPSDKDM4E
SCHEMBL13508029 0.86 MCL1 (0.42) ALDH1A1HSD17B10HPGDL3MBTL1TSHR
SCHEMBL16068030 0.86 ENPP3 (0.36) ALDH1A1HSD17B10PSDKDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 ALDH1A1 119/4885HSD17B10 1287/4885HPGD 1044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback